RENAU.UNSP.ARD 1/5 EO-20 (56S0) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.035x

Based on the latest financial reports, RENAU.UNSP.ARD 1/5 EO-20 (56S0) has a cash flow conversion efficiency ratio of 0.035x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€147.90 Million ≈ $172.91 Million USD) by net assets (€4.25 Billion ≈ $4.97 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RENAU.UNSP.ARD 1/5 EO-20 market cap and net worth for the company's overall valuation and market capitalisation.

RENAU.UNSP.ARD 1/5 EO-20 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's cash flow conversion efficiency has evolved over time, based on yearly financial data.

RENAU.UNSP.ARD 1/5 EO-20 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RENAU.UNSP.ARD 1/5 EO-20 ranked by their cash flow conversion efficiency. Explore RENAU.UNSP.ARD 1/5 EO-20 (56S0) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Vonovia SE
XETRA:VNA
0.007x
Norsk Hydro ASA
OL:NHY
0.081x
Heico Corporation
NYSE:HEI
0.054x
Vale S.A
BA:VALE
0.061x
China Shipbuilding Industry Co Ltd
SHG:601989
-0.021x
ASICS CORP.(UNSP.ADR)/1
F:ASI
N/A
Bank of Beijing Co Ltd
SHG:601169
-0.375x
IONQ Inc
NYSE:IONQ
-0.030x

Annual Cash Flow Conversion Efficiency for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)

The table below shows the annual cash flow conversion efficiency of RENAU.UNSP.ARD 1/5 EO-20 from 2022 to 2025. View current stock price of RENAU.UNSP.ARD 1/5 EO-20 for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €4.13 Billion
≈ $4.82 Billion
€692.20 Million
≈ $809.25 Million
0.168x -17.18%
2024-12-31 €4.02 Billion
≈ $4.70 Billion
€815.10 Million
≈ $952.94 Million
0.203x -27.43%
2023-12-31 €2.67 Billion
≈ $3.13 Billion
€746.40 Million
≈ $872.62 Million
0.279x +14.62%
2022-12-31 €2.51 Billion
≈ $2.94 Billion
€612.30 Million
≈ $715.84 Million
0.244x --

About RENAU.UNSP.ARD 1/5 EO-20

F:56S0 Germany Medical Instruments & Supplies
Market Cap
$24.11 Billion
€20.62 Billion EUR
Market Cap Rank
#1479 Global
#329 in Germany
Share Price
€21.20
Change (1 day)
+6.00%
52-Week Range
€14.60 - €21.80
All Time High
€35.31
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more